Compare Marriott International Inc (MAR) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marriott International Inc vs Twist Bioscience Corp — how do they compare? Marriott International Inc trades at $360.95 (market cap $92.96B), while Twist Bioscience Corp trades at $157.06 (market cap $10.32B). The key difference: Marriott International Inc is far larger — about 9× Twist Bioscience Corp's market cap, and Marriott International Inc pays a 0.82% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marriott International Inc for 164 Days and Twist Bioscience Corp for 27 Days on average.
| MAR | TWST | |
|---|---|---|
Market Cap | $92.96B | $10.32B |
Volume | 1,173,633 | 5,894,998 |
Sector | Consumer Cyclical | Health |
52-Week High | $402.54 | $205.00 |
52-Week Low | $259.04 | $25.45 |
Typical Hold Time | 164 Days | 27 Days |
Enterprise Value | $110.28B | $10.24B |
Dividend Yield | 0.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marriott International (MAR) trades at $361.08, showing minimal daily movement with a slight decline of 0.06%. The stock maintains a bullish technical signal with strong moving average support and trades near key resistance at $360. Fundamentally, the company reported solid Q2 2026 earnings beat with $3.19 EPS versus $3.08 expected, continuing revenue growth to $26.19B in 2025, though valuation ratios remain elevated with P/E at 36.9. Recent developments include new technology partnerships and upcoming dividend payment.
Marriott presents a mixed investment case with strong operational performance offset by high valuation multiples. The consensus price target of $386.71 suggests 7% upside potential, supported by 44% analyst buy ratings. Key risks include rising debt levels with debt-to-asset ratio reaching 58.83% and potential travel sector volatility. The company's dominant market position and continued travel demand provide growth catalysts, but investors should weigh valuation concerns against fundamental strength.
TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.
The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
